Return to homepagePandemic Pact

Validation of selected commercial serological assays for diagnosis of COVID-19

  • Funded by Qatar National Research Fund
  • Total publications:7 publications

Grant number: RRC-2-032

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    Qatar National Research Fund

  • Principal Investigator

    Gheyath K Nasrallah

  • Research Location

    Qatar

  • Lead Research Institution

    Qatar University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.

Effect of multiple freeze-thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies.

Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.

Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals.

Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review.

Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits.

The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review.